Another record quarter exemplifying strong growth ahead of...

Another record quarter exemplifying strong growth ahead of market trajectory. The pull back today was a typical reaction really (buy the rumour sell the fact) and imo will be short lived. At the conference call the CEO said he didn't want to sound like a broken record but RMD was growing at twice the market rate (market 20%, RMD 44%). Main competitor Respironics only 17%. With new products in the pipeline for remainder of FY07 he is anticipating continuing strong global growth. And he was very exited about the extremely robust operating cash flow of $35m to take advantage of that strong global growth. I listened to most of the call and was very impressed with how all the questions were answered in great detail. This is a very good company imo selling a very good product and is a great long term growth stock.